A carregar...

A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence

We developed a test to predict which patients will achieve pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) and which will have residual disease (RD). Gene expression data from pretreatment biopsies of patients with all breast cancer subtypes were combined into a 519-patient co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Fournier, Marcia V., Goodwin, Edward C., Chen, Joan, Obenauer, John C., Tannenbaum, Susan H., Brufsky, Adam M.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795899/
https://ncbi.nlm.nih.gov/pubmed/31619719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-51335-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!